Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1998-06-19
2000-02-08
Davenport, Avis M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 169, 424 165, 514 12, 514 13, 514 14, 514 15, 514 16, 514 17, 514 18, A61K 5100, A61K 3800, C07K 500, C07K 700
Patent
active
060225203
ABSTRACT:
This invention relates to radiolabeled scintigraphic imaging agents, and methods and reagents for producing such agents. Specifically, the invention relates to specific binding compounds, including peptides, that bind to a platelet receptor that is the platelet GPIIb/IIIa receptor, methods and kits for making such compounds, and methods for using such compounds labeled with technetium-99m via a covalently-linked radiolabel-binding moiety to image thrombi in a mammalian body.
REFERENCES:
patent: 5645815 (1997-07-01), Dean et al.
Dean Richard T.
Lister-James John
Davenport Avis M.
Diatide, Inc.
McDaniels Patricia A.
Noonan Kevin E.
LandOfFree
Radiolabeled compounds for thrombus imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabeled compounds for thrombus imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled compounds for thrombus imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1678446